向C3d的H因子在疾病模型中抑制了组织补充,并减少了淋巴细胞损伤,而不影响循环补充
Fei Liu1, Sarah T Ryan1, Kelly C Fahnoe1
1Q32 Bio, Waltham, MA 02451, USA.
Molecular therapy : the journal of the American Society of Gene Therapy
|February 21, 2024
概括
这项研究引入了向的融合蛋白,可以局部抑制补充,减少皮肤和脏的疾病活性,而无需系统性免疫抑制. 这种方法为补充介导疾病提供了更安全,更有效的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- 系统补充抑制剂由于大量循环补充剂,因此面临有效性和感染风险的挑战.
- 针对当地补充的目标提供了一个潜在的解决方案,以克服这些局限性.
研究的目的:
- 开发和评估用于局部补体抑制的新型抗体融合蛋白.
- 评估针对组织结合的补充成分的疗效和安全性.
主要方法:
- 工程抗体融合蛋白结合了H因子 (fH1-5) 和抗C3d单克隆抗体 (C3d-mAb-2fH).
- 在人类皮肤和灵长类动物损伤模型中,验证了蛋白质与沉积补充剂的结合.
- 评估了皮肤损伤和膜性脏病的动物模型中的组织补充抑制和疾病修饰.
主要成果:
- 融合蛋白被证明与患病皮肤中沉积的C3d结合,并在体内局部地与活化补充物结合.
- 剂量>1 mg/kg在没有全身阻塞的动物模型中实现了>75%的组织补充抑制.
- 在大鼠模型中,淋巴细胞特异性抑制降低了蛋白尿,并保留了脏结构.
结论:
- 用C3d-mAb-2fH融合蛋白向本地组织补充剂提供了持久和有效的阻塞.
- 这种局部化方法避免了系统性抑制,这表明它对补充介导疾病具有广泛的适用性.
- 该策略提供了一个有希望的治疗途径,降低了感染风险.
更多相关视频
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
17.8K
06:54Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
Published on: June 15, 2019
6.0K
相关概念视频
Complement System
10.8K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.8K
Hypersensitivity Reactions: Cytolytic Reactions
221
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
221
